Evidence map›Paper›PMID 21843011›Full record

ArticleExperimental and clinical psychopharmacology2011

Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains.

Morgane Thomsen, Rebecca J Ralph, S Barak Caine

Open access · greenAbstract read
In one paragraph

Article in Experimental and clinical psychopharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. D2 autoreceptors gate vulnerability to cocaine use disorder.bioRxiv : the preprint server for biology · 2026
    Article
  2. D1 receptor hypersensitivity in mice with low striatal D2 receptors facilitates select cocaine behaviors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cocaine self-administration in dopamine D₃ receptor knockout mice.Experimental and clinical psychopharmacology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Morgane ThomsenAlcohol and Drug Abuse Research Center. Harvard Medical School and McLean Hospital, Mail Stop 214, 115 Mill Street, Belmont, MA 02478, USA. mthomsen@mclean.harvard.edu
Rebecca J Ralph
S Barak Caine
McLean Hospital · USHarvard University · US

Funding

DRUG ABUSE RESEARCH TRAINING PROGRAMT32DA007252 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI MELLO, NANCY K. · 1991 to 2011
$3.0M
COCAINE SELF ADMINISTRATION IN DOPAMINE KNOCKOUT MICER29DA012142 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI CAINE, SIMON BARAK · 1999 to 2003
$414k
NIDA NIH HHS DA07252NIDA NIH HHS DA12142NIDA NIH HHS R29 DA012142NIDA NIH HHS T32 DA007252
6 · The paper itself

Abstract

Many neurological and psychiatric disorders are treated with dopamine modulators. Studies in mice may reveal genetic factors underlying those disorders or responsiveness to various treatments, and species and strain differences both complicate the use of mice and provide valuable tools. We evaluated psychomotor effects of the dopamine D₁-like agonist R-6-Br-APB and the dopamine D₂-like agonist quinelorane using a locomotor activity procedure in 15 mouse strains (inbred 129S1/SvImJ, 129S6/SvEvTac, 129X1/SvJ, A/J, BALB/cByJ, BALB/cJ, C3H/HeJ, C57BL/6J, CAST/EiJ, DBA/2J, FVB/NJ, SJL/J, SPRET/EiJ, outbred Swiss Webster, and CD-1) and Sprague-Dawley rats, using groups of both females and males. Both D₁ and D₂ stimulation produced hyperactivity in the rats, and surprisingly, only two mouse strains were similar in that regard (C3H/HeJ, SPRET/EiJ). In contrast, the majority of mouse strains exhibited hyperactivity only with D₁ stimulation, whereas D₂ stimulation had no effect or decreased activity. BALB substrains, A/J and FVB/NJ mice showed only decreased activity after either D₁ or D₂ stimulation. CAST/EiJ mice exhibited hyperactivity exclusively with D₂ stimulation. Sex differences were observed but no systematic trend emerged: For example, of the five strains in which a main factor of sex was identified for the stimulant effects of the D₁ agonist, responsiveness was greatest in females in three of those strains and in males in two of those strains. These results should aid in the selection of mouse strains for future studies in which D₁ or D₂ responsiveness is a necessary consideration in the experimental design.

Indexed as

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineAnimalsCentral Nervous System StimulantsDopamineDopamine AgonistsDrug Evaluation, PreclinicalFemaleHyperkinesisMaleMiceMice, Inbred BALB CMice, Inbred C3HMice, Inbred C57BLMice, Inbred DBAMice, Inbred StrainsModels, Animal2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine3-allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepineCentral Nervous System StimulantsDopamineDopamine AgonistsquineloraneQuinolines

Identifiers

PMID21843011
PMCPMC3319345
OpenAlexW1971657628

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.